Remimazolam benzenesulfonate

• CAT Number: I000073
• CAS Number: 1001415-66-2
• Molecular Formula: C27H25BrN4O5S
• Molecular Weight: 597.48
• Purity: ≥95%
• Target: GABA Receptor
• Solubility: DMSO: ≥ 29 mg/mL
• Storage: Store at -20°C
• IUPAC Name: benzenesulfonic acid;methyl 3-[(4S)-8-bromo-1-methyl-6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate
• InChI: InChI=1S/C21H19BrN4O2.C6H6O3S/c1-13-12-24-21-17(7-9-19(27)28-2)25-20(16-5-3-4-10-23-16)15-11-14(22)6-8-18(15)26(13)21;7-10(8,9)6-4-2-1-3-5-6/h3-6,8,10-12,17H,7,9H2,1-2H3;1-5H,(H,7,8,9)/t17-;/m0./s1
• InChIKey: QMTKNJZIWGTNTE-LMOVPXPDSA-N
• SMILES: CC1=CN=C2N1C3=C(C=C(C=C3)Br)C(=N[C@H]2CCC(=O)OC)C4=CC=CC=N4.C1=CC=C(C=C1)S(=O)(=O)O

Remimazolam Benzenesulfonate(CAT: I000073) is an ultra-short-acting benzodiazepine derivative used as a sedative and anesthetic. It acts on GABAA receptors, enhancing the inhibitory effects of GABA and producing sedation, anxiolysis, and amnesia. Its rapid onset and short duration of action make it ideal for procedural sedation and induction of anesthesia, especially in outpatient or short-duration procedures. Remimazolam Benzenesulfonate is extensively studied for its pharmacokinetic and pharmacodynamic properties, as well as its safety profile, which includes rapid recovery times and a lower risk of respiratory depression compared to other sedatives. It is a valuable tool in clinical anesthesiology and pharmacology research.